The role of 5-HT1A autoreceptors and α 1-adrenoceptors in the modulation of 5-HT release—III. Clozapine and the novel putative antipsychotic S 16924

[1]  U. Spampinato,et al.  8-OH-DPAT, a 5-HT1A agonist and ritanserin, a 5-HT2A/C antagonist, reverse haloperidol-induced catalepsy in rats independently of striatal dopamine release , 1997, Psychopharmacology.

[2]  G. Bartoszyk,et al.  5-HT1A receptors are not involved in clozapine's lack of cataleptogenic potential , 1996, Neuropharmacology.

[3]  T. Sharp,et al.  The role of 5-HT1A autoreceptors and α 1-Adrenoceptors in the inhibition of 5-HT release—II NAN-190 and SDZ 216-525 , 1996, Neuropharmacology.

[4]  M. Millan,et al.  Clozapine is a partial agonist at cloned, human serotonin 5-HT1A receptors , 1996, Neuropharmacology.

[5]  Allan Fletcher,et al.  Electrophysiological, biochemical, neurohormonal and behavioural studies with WAY-100635, a potent, selective and silent 5-HT1A receptor antagonist , 1995, Behavioural Brain Research.

[6]  L. Steardo,et al.  New Insights into the Biology of Schizophrenia through the Mechanism of Action of Clozapine , 1995, Neuropsychopharmacology.

[7]  G. Tsujimoto,et al.  Selectivity of the imidazoline α‐adrenoceptor agonists (oxymetazoline and cirazoline) for human cloned α1‐adrenoceptor subtypes , 1995 .

[8]  M. Millan,et al.  P-4-12 In vitro and ex vivo patterns of occupation of 5-HT2A and α1-adrenergic as compared to dopamine D2 receptors by novel antipsychotics , 1995, European Neuropsychopharmacology.

[9]  I A Cliffe,et al.  A pharmacological profile of the selective silent 5-HT1A receptor antagonist, WAY-100635. , 1995, European journal of pharmacology.

[10]  S. Hjorth,et al.  Studies on the role of 5-HT1A autoreceptors and α 1-adrenoceptors in the inhibition of 5-HT release—I. BMY7378 and prazosin , 1995, Neuropharmacology.

[11]  V. Hillegaart,et al.  Stimulation of median, but not dorsal, raphe 5-HT1A autoreceptors by the local application of 8-OH-DPAT reverses raclopride-induced catalepsy in the rat , 1995, Neuropharmacology.

[12]  F. Artigas,et al.  Clozapine decreases serotonin extracellular levels in the nucleus accumbens by a dopamine receptor-independent mechanism , 1995, Neuroscience Letters.

[13]  M. Millan,et al.  Clozapine inhibits serotoninergic transmission by an action at alpha 1-adrenoceptors not at 5-HT1A receptors. , 1994, European journal of pharmacology.

[14]  I. Lucki,et al.  Serotonergic involvement in haloperidol-induced catalepsy. , 1993, The Journal of pharmacology and experimental therapeutics.

[15]  S. Hjorth,et al.  Serotonin 5‐HT1A Autoreceptor Blockade Potentiates the Ability of the 5‐HT Reuptake Inhibitor Citalopram to Increase Nerve Terminal Output of 5‐HT In Vivo: A Microdialysis Study , 1993, Journal of neurochemistry.

[16]  Coward Dm,et al.  General pharmacology of clozapine. , 1992 .

[17]  Eric R. Marsh,et al.  Do Central Antiadrenergic Actions Contribute to the Atypical Properties of Clozapine? , 1992, British Journal of Psychiatry.

[18]  S. Hjorth,et al.  The 5-HT1A receptor agonist, 8-OH-DPAT, preferentially activates cell body 5-HT autoreceptors in rat brain in vivo , 1988, Naunyn-Schmiedeberg's Archives of Pharmacology.

[19]  C. de Montigny,et al.  Effects of the 5-hydroxytryptamine receptor antagonist, BMY 7378, on 5-hydroxytryptamine neurotransmission: electrophysiological studies in the rat central nervous system. , 1988, The Journal of pharmacology and experimental therapeutics.

[20]  L. Cervo,et al.  8-hydroxy-2-(di-N-propylamino) tetralin, a selective serotonin1A receptor agonist, blocks haloperidol-induced catalepsy by an action on raphe nuclei medianus and dorsalis , 1988, Neuropharmacology.

[21]  G. Aghajanian,et al.  Electrophysiological responses of serotoninergic dorsal raphe neurons to 5‐HT1A and 5‐HT1B agonists , 1987, Synapse.

[22]  G. Paxinos,et al.  The Rat Brain in Stereotaxic Coordinates , 1983 .

[23]  G. Aghajanian,et al.  Noradrenergic innervation of serotonergic neurons in the dorsal raphe: Demonstration by electron microscopic autoradiography , 1981, Brain Research.

[24]  G. Aghajanian,et al.  Suppression of firing activity of 5-HT neurons in the dorsal raphe by alpha-adrenoceptor antagonists , 1980, Neuropharmacology.